Cliantha Research Limited   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Ahmedabad India (2004)

Organization Overview

First Clinical Trial
2012
NCT01618825
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Cliantha Research | Cliantha Research, India | Cliantha Research Limited | Cliantha Research Limited, India

Active Ingredients

Drugs in Phase 4 Trials (3)

Key: Cliantha Research Limited (1) Acquired (2)

azelastine (astelin) (1 trial)

buprenorphine (1 trial)

naloxone (narcan) (1 trial)

Drugs in Phase 3 Trials (7)

Key: Cliantha Research Limited (2) Acquired (5)

avobenzone (shade uvaguard) (1 trial)

benzoyl peroxide (clearasil) (1 trial)

clindamycin (cleocin) (1 trial)

ecamsule (Mexoryl SX) (1 trial)

nicotine (nicorette) (1 trial)

octocrylene (1 trial)

titanium (1 trial)

Drugs in Phase 2 Trials (11)

Key: Cliantha Research Limited (1) Acquired (10)

3804-250a (2 trials)

3804-291 (1 trial)

bio-11006 (1 trial)

birch allergen (2 trials)

btl-tml-hsv (1 trial)

loteprednol (lotemax) (1 trial)

oak tree allergen (1 trial)

short ragweed pollen allergen (2 trials)

spinosad (natroba) (5 trials)

timothy grass pollen allergen extract (Grastek) (2 trials)

trifolium pratense (1 trial)

Drugs in Phase 1 Trials (16)

Key: Cliantha Research Limited (4) Acquired (12)

aluminum hydroxide (Gaviscon) (1 trial)

anastrozole (arimidex) (2 trials)

cat epidermis allergen (1 trial)

duloxetine (Cymbalta) (2 trials)

enoxaparin (lovenox) (1 trial)

eszopiclone (lunesta) (2 trials)

house dust mite allergen (1 trial)

ibandronate (boniva) (1 trial)

lamotrigine (lamictal) (2 trials)

metoprolol (lopressor) (3 trials)

rotigotine (neupro) (1 trial)

sodium chloride (1 trial)

sumatriptan (zecuity) (1 trial)

tacrolimus (prograf) (2 trials)

vortioxetine (trintellix) (3 trials)

zafirlukast (accolate) (1 trial)

Drugs in Other Trials (1)

crizotinib (xalkori) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Lung Neoplasms (Phase 2)

Malnutrition (Phase 1)

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 4)

Rhinitis, Allergic, Seasonal (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 46
  • # of Trial APIs: 38